Cargando…

Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges

Detalles Bibliográficos
Autores principales:	Pagni, Roberta Liberato, Pelegrin, Guilherme Formoso, Moreno, Ana Carolina Ramos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745375/ https://www.ncbi.nlm.nih.gov/pubmed/36523312 http://dx.doi.org/10.21037/tcr-22-2158

Ejemplares similares

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
por: Pagni, Roberta Liberato, et al.
Publicado: (2022)

Human Papillomavirus: Oral Lesions and Vaccination
por: Di Spirito, Federica
Publicado: (2023)

Human Papillomavirus Vaccination: Past, Present and Future
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2022)

Human Papillomavirus Infection Is an Unresolved Challenge in Assisted Reproductive Techniques
por: Sadeghi, Mohammad Reza
Publicado: (2022)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines
por: Yoneda, Makoto
Publicado: (2016)

Global challenges of implementing human papillomavirus vaccines
por: Graham, Janice E, et al.
Publicado: (2011)

Therapeutic Vaccine Strategies against Human Papillomavirus
por: Khallouf, Hadeel, et al.
Publicado: (2014)

Moral dilemma(s) in human papillomavirus vaccination – revisiting the role of the herd effect
por: Lehtinen, Matti, et al.
Publicado: (2021)

Human papillomavirus vaccines: A great leap forward
por: Frevert, Marie Louise, et al.
Publicado: (2022)

Human Polyomaviruses and Papillomaviruses
por: Moens, Ugo
Publicado: (2018)

Human Papillomavirus and Cancer
por: Viale, Pamela Hallquist
Publicado: (2018)

Human Papillomavirus and Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

Prevention of Human Papillomavirus-Related Malignancies of the Female Genital Tract
por: Koliopoulos, George, et al.
Publicado: (2011)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives
por: Yared, Nicholas, et al.
Publicado: (2021)

APOBEC3 in papillomavirus restriction, evolution and cancer progression
por: Warren, Cody J., et al.
Publicado: (2015)

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
por: Chin’ombe, Nyasha, et al.
Publicado: (2014)

Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach
por: Kawana, Kei, et al.
Publicado: (2012)

Human papillomavirus: wearisome or awesome issue?
por: Cho, Nam Hoon
Publicado: (2014)

Human papillomavirus: The disease and prevention strategies
por: Akhtar, Mohammed
Publicado: (2004)

KDM2B in papillomavirus-related cancer
por: Peta, Elektra, et al.
Publicado: (2018)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus
por: Wu, Wai-Hong, et al.
Publicado: (2011)

MAbImprove: A French “Laboratoire d’excellence” (LabEx) dedicated to therapeutic antibodies
por: Pèlegrin, André, et al.
Publicado: (2014)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

State statutes and regulations related to human papillomavirus vaccination
por: Hoss, Aila, et al.
Publicado: (2019)

Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
por: Sano, Daisuke, et al.
Publicado: (2019)

Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
por: Nayereh, Khadem Ghaebi, et al.
Publicado: (2012)

Spotlight on Human Papillomavirus Vaccination Coverage: Is Nigeria Making Any Progress?
por: Okolie, Elvis Anyaehiechukwu, et al.
Publicado: (2023)

ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape
por: Cid Arregui, A, et al.
Publicado: (2012)

Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil
por: Silva, Tércia Moreira Ribeiro Da, et al.
Publicado: (2022)

Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges
por: Msyamboza, Kelias Phiri, et al.
Publicado: (2017)

Human papillomavirus vaccination in adults: impact, opportunities and challenges – a meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2021)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Progress in Therapeutics
Publicado: (1893)

Factors Associated with Human Papillomavirus Vaccination Among Diverse Adolescents in a Region with Low Human Papillomavirus Vaccination Rates
por: Kepka, Deanna, et al.
Publicado: (2018)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qhcs1hv4b1f6p3c8dj66054bo3